Simon Pedder, PhD

Prior to that, he had leadership roles as Chief Business and Strategy Officer for Athenex, President and CEO of Cellectar Biosciences, and President and CEO of Chelsea Therapeutics International, Ltd.
Previous positions at Roche included Life Cycle Leader and Global Project Leader of Pegasys/IFN and Head of Hepatitis Franchise. Prior to that, he was Clinical Leader for a number of development compounds at Roche. Dr. Pedder served on the Board of Directors of numerous public and private companies.

During his longstanding career in pharmaceutical development, Dr. Pedder played key roles in the successful development and commercialization of multiple proprietary pharmaceutical products including Tasmar®, Pegasys®, Copegus®, Northera® and Klisyri®.